Open AccessThe Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial
Author(s) -
Grace Yu,
Brittany Weldon,
S. Neale-May,
Kari C. Nadeau
Publication year - 2012
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000336391
Subject(s) - peanut allergy , medicine , anaphylaxis , oral immunotherapy , allergy , oral food challenge , food allergy , asthma , adverse effect , single center , dermatology , immunotherapy , immunoglobulin e , immunology , immune system , antibody
Peanut allergy is the leading cause of food-related anaphylaxis, and accidental exposures are common. Oral immunotherapy (OIT) has been posited as a potential treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom